Natalia Blanco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalia Blanco has a total of 244 co-authors. Here are the top co-authors by number of shared publications:
- Marie-Claude C. Lavoie
Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA
7 shared publications - Kristen Alyce Stafford
Center for International Health, Education and Biosecurity, Institute of Human Virology, School of Medicine, University of Maryland, 725 W Lombard St, Baltimore, MD, 21201, United States, 1 410-706-8614
6 shared publications - Surbhi Leekha
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA
5 shared publications Anna Winters
Akros, Lusaka, Zambia
4 shared publications- Anthony D. Harris
Department of Epidemiology and Public Health, University of Maryland School of Medicine , Baltimore, Maryland
4 shared publications - Cassidy Wayne Claassen
Center for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, MD, USA.
4 shared publications
Latest Publications
- Open Access
- 17 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0340782
Place susceptibility index mapping at local government scale from population-based survey for Sub-Saharan Africa
The Place Susceptibility Index (PSI) has the potential to be a critical tool in effectively managing infectious disease outbreaks or natural disasters in Africa. However, PSI availability for the African continent is limited and often, when available, is only at the national or regional level. Thus, lacking the required details to support locally relevant decision-making to support such activities. Here, outlined the method for modeling PSI at the 3rd-order administrative level for selected African Countries. This method combined Bayesian spatial statistical modeling with the utilization of the Population-based HIV Impact Assessments (PHIA) data and geospatial covariates. Using the Jenks Classification, substantial variations in PSI classes across the countries were observed. Across the 10 countries, about 45% of the spatial units were categorized as the low and relatively low susceptibility classes, while around 31% belonged to the high and very high classes. Botswana had 17% of the spatial units classified as high or very high, while Zambia had as many as 58% of its spatial units in these classes. The analysis showcased wide variations in susceptibility across countries, thus highlighting heterogeneity often missed in national datasets. This thereby provides insight into regions and areas within each country with the potential for severe negative outcomes from disease outbreaks and natural or man-made disasters. The datasets presented here are publicly available as part of the INFORM Africa Research project, and provide an evidence base to inform strategic decision-making.
- 17 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0340782
Open AccessPlace susceptibility index mapping at local government scale from population-based survey for Sub-Saharan Africa
The Place Susceptibility Index (PSI) has the potential to be a critical tool in effectively managing infectious disease outbreaks or natural disasters in Africa. However, PSI availability for the African continent is limited and often, when available, is only at the national or regional level. Thus, lacking the required details to support locally relevant decision-making to support such activities. Here, outlined the method for modeling PSI at the 3rd-order administrative level for selected African Countries. This method combined Bayesian spatial statistical modeling with the utilization of the Population-based HIV Impact Assessments (PHIA) data and geospatial covariates. Using the Jenks Classification, substantial variations in PSI classes across the countries were observed. Across the 10 countries, about 45% of the spatial units were categorized as the low and relatively low susceptibility classes, while around 31% belonged to the high and very high classes. Botswana had 17% of the spatial units classified as high or very high, while Zambia had as many as 58% of its spatial units in these classes. The analysis showcased wide variations in susceptibility across countries, thus highlighting heterogeneity often missed in national datasets. This thereby provides insight into regions and areas within each country with the potential for severe negative outcomes from disease outbreaks and natural or man-made disasters. The datasets presented here are publicly available as part of the INFORM Africa Research project, and provide an evidence base to inform strategic decision-making.
- Open Access
- 14 October 2025
- Published by Springer Nature in BMC Genomics
- Vol. 26 (1) , 1-12
Genomic diversity and surveillance of SARS-CoV-2 in Nigeria
As Nigeria has the sixth-highest population in the world and a significant amount of inbound and outbound travel, the characterization of SARS-CoV-2 genomic diversity across the country is critical for understanding novel pandemic dynamics. We describe the genomic diversity of SARS-CoV-2 in Nigeria throughout the COVID-19 pandemic and examine the coverage of Nigeria's genomic surveillance system. Genome sequences and sample metadata were downloaded from the GISAID repository. A beta regression was used to test for a relationship between fully resolved nucleotide proportion over time, as a proxy for data quality. Sample and sequencing source were compared to assess geographic coverage. A total of 7759 COVID-19 sequences collected from February 2020 to March 2023 were included. The majority were collected in 2021 (76.6%) and South West (43%). Eleven states (30%) reported 10 or fewer SARS-CoV-2 genomes across the entire period. The genome sequences submitted to GISAID from Nigeria were of high quality with very few unresolved nucleotides. Waves 4 and 5, predominantly Omicron lineages, show higher diversity around position 23 kb than the other waves. Overall, the Nigeria Centre for Disease Control (NCDC) and state-run hospitals were the largest contributors to the sample collection efforts during this study period. However, the collection efforts shifted over time from NCDC in waves 1–3 to regional hospitals and other healthcare facilities in waves 4–5, although this pattern varied by geopolitical zone (GPZ). Sequencing efforts also shifted from research laboratories during the first waves to NCDC during waves 4 and 5. The findings suggest the need for a coordinated sequencing strategy and standardized protocols to improve genomic surveillance during future outbreaks of existing and novel pathogens. A network of sequencing laboratories that includes at least one in each GPZ, linked to and coordinated by the national reference laboratory at NCDC might provide more balanced coverage for future pandemics and pathogen surveillance.
- 14 October 2025
- Published by Springer Nature in BMC Genomics
- Vol. 26 (1) , 1-12
Open AccessGenomic diversity and surveillance of SARS-CoV-2 in Nigeria
As Nigeria has the sixth-highest population in the world and a significant amount of inbound and outbound travel, the characterization of SARS-CoV-2 genomic diversity across the country is critical for understanding novel pandemic dynamics. We describe the genomic diversity of SARS-CoV-2 in Nigeria throughout the COVID-19 pandemic and examine the coverage of Nigeria's genomic surveillance system. Genome sequences and sample metadata were downloaded from the GISAID repository. A beta regression was used to test for a relationship between fully resolved nucleotide proportion over time, as a proxy for data quality. Sample and sequencing source were compared to assess geographic coverage. A total of 7759 COVID-19 sequences collected from February 2020 to March 2023 were included. The majority were collected in 2021 (76.6%) and South West (43%). Eleven states (30%) reported 10 or fewer SARS-CoV-2 genomes across the entire period. The genome sequences submitted to GISAID from Nigeria were of high quality with very few unresolved nucleotides. Waves 4 and 5, predominantly Omicron lineages, show higher diversity around position 23 kb than the other waves. Overall, the Nigeria Centre for Disease Control (NCDC) and state-run hospitals were the largest contributors to the sample collection efforts during this study period. However, the collection efforts shifted over time from NCDC in waves 1–3 to regional hospitals and other healthcare facilities in waves 4–5, although this pattern varied by geopolitical zone (GPZ). Sequencing efforts also shifted from research laboratories during the first waves to NCDC during waves 4 and 5. The findings suggest the need for a coordinated sequencing strategy and standardized protocols to improve genomic surveillance during future outbreaks of existing and novel pathogens. A network of sequencing laboratories that includes at least one in each GPZ, linked to and coordinated by the national reference laboratory at NCDC might provide more balanced coverage for future pandemics and pathogen surveillance.
- Open Access
- 6 April 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 82, 103176
The effects of the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) program on HIV incidence and other health-related outcomes among adolescent girls and young women: a systematic review and meta-analysis
- 6 April 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 82, 103176
Open AccessThe effects of the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) program on HIV incidence and other health-related outcomes among adolescent girls and young women: a systematic review and meta-analysis
- Open Access
- 30 January 2025
- Published by CSIRO Publishing in Sexual Health
- Vol. 22 (1)
‘Does human papillomavirus (HPV) cause cancer?’ – A cross-sectional study of HPV awareness among sexual minority men in Nigeria
Background: Human papillomavirus (HPV)-associated cancers are a global concern, particularly for sexual minority men (SMM). Understanding awareness and the determinants of these beliefs is crucial for developing educational programs to reduce HPV-associated cancers. This study explored awareness and determinants of beliefs about HPV’s carcinogenicity among SMM living with and without HIV in Nigeria. Methods: Participants were recruited through secure social media platforms in Abuja, Nigeria. REDCap surveys captured demographics, sexual practices and participants’ beliefs regarding HPV’s role in cancer. Multivariable logistic regression modeling was used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CI) for the relationships between individual characteristics and belief levels stratified by those living with and without HIV. Results: Of 982 participants, the median age was 29 years (interquartile range: 26–34); 64.1% were living with HIV, and 9.7% believed HPV causes cancer. Awareness was highest for anal (82.1%) and penile cancers (15.8%) and less so for oropharyngeal and female HPV-associated cancers (range: 3–7%). Anogenital warts increased the odds of awareness for SMM living with HIV (aOR: 6.4, CI: 3.0–13.6) and for individuals without HIV (aOR: 4.8, CI: 1.6–14.2). Living with HIV for over 6 years was independently associated with a two-fold increased knowledge about HPV’s carcinogenicity (aOR: 2.1, CI: 1.1–4.1). Conclusions: Awareness of HPV’s carcinogenicity was low; however, those who were aware were more likely to identify male HPV-associated cancers relevant to their own cancer risk. Formalizing targeted education in HIV care settings may promote knowledge and advocacy for prevention strategies.
- 30 January 2025
- Published by CSIRO Publishing in Sexual Health
- Vol. 22 (1)
Open Access‘Does human papillomavirus (HPV) cause cancer?’ – A cross-sectional study of HPV awareness among sexual minority men in Nigeria
Background: Human papillomavirus (HPV)-associated cancers are a global concern, particularly for sexual minority men (SMM). Understanding awareness and the determinants of these beliefs is crucial for developing educational programs to reduce HPV-associated cancers. This study explored awareness and determinants of beliefs about HPV’s carcinogenicity among SMM living with and without HIV in Nigeria. Methods: Participants were recruited through secure social media platforms in Abuja, Nigeria. REDCap surveys captured demographics, sexual practices and participants’ beliefs regarding HPV’s role in cancer. Multivariable logistic regression modeling was used to estimate adjusted odds ratios (aOR) and 95% confidence intervals (CI) for the relationships between individual characteristics and belief levels stratified by those living with and without HIV. Results: Of 982 participants, the median age was 29 years (interquartile range: 26–34); 64.1% were living with HIV, and 9.7% believed HPV causes cancer. Awareness was highest for anal (82.1%) and penile cancers (15.8%) and less so for oropharyngeal and female HPV-associated cancers (range: 3–7%). Anogenital warts increased the odds of awareness for SMM living with HIV (aOR: 6.4, CI: 3.0–13.6) and for individuals without HIV (aOR: 4.8, CI: 1.6–14.2). Living with HIV for over 6 years was independently associated with a two-fold increased knowledge about HPV’s carcinogenicity (aOR: 2.1, CI: 1.1–4.1). Conclusions: Awareness of HPV’s carcinogenicity was low; however, those who were aware were more likely to identify male HPV-associated cancers relevant to their own cancer risk. Formalizing targeted education in HIV care settings may promote knowledge and advocacy for prevention strategies.
- Open Access
- 13 January 2025
- Published by Springer Nature in Discover Public Health
- Vol. 22 (1) , 1-11
Enhanced adherence counselling completion rates, viral load suppression in people with HIV in Africa: systematic review and meta-analysis
- 13 January 2025
- Published by Springer Nature in Discover Public Health
- Vol. 22 (1) , 1-11
Open AccessEnhanced adherence counselling completion rates, viral load suppression in people with HIV in Africa: systematic review and meta-analysis
- Open Access
- 31 December 2024
- Published by Taylor & Francis in Global Health Action
- Vol. 17 (1) , 2446043
Social vulnerability index associated with higher COVID-19 seroprevalence in Nigeria
Social vulnerability has been shown to be a strong predictor of disparities in health outcomes. A common approach to estimating social vulnerability is using a composite index, such as the social vulnerability index (SVI), which combines multiple factors corresponding to key social determinants of health. Lawal and Osayomi created an SVI to explore key social determinants of health-related COVID-19 infection among the Nigerian population. This study explored the association of COVID-19 SVI with COVID-19 seroprevalence using a large household survey in Nigeria. Weighted COVID-19 seroprevalence estimates at the Local Government Areas (LGA) were estimated and merged with the Lawal and Osayomi SVI, also at the LGA-level. Linear regression models were constructed to evaluate the relationship between the SVI and COVID-19 seroprevalence. The effect of SVI was evaluated both as a continuous variable and categorized into quintiles to evaluate dose-response effects. Our results confirmed a positive relationship between social vulnerability and COVID-19 infection in four states and the Federal Capital Territory in Nigeria. Compared to class 1 (the least vulnerable group), COVID-19 seroprevalence was, on average, 9.21% and 6.42% higher in classes 4 and 5 LGAs, respectively, after adjustment by phase of the survey. The effect was particularly strong farther into the pandemic (June 2021), when COVID-19 mitigation measures were relaxed. In conclusion, SVI can potentially be a useful tool to effectively prioritize communities for resource allocation as part of emergency response and preparedness in Africa.
- 31 December 2024
- Published by Taylor & Francis in Global Health Action
- Vol. 17 (1) , 2446043
Open AccessSocial vulnerability index associated with higher COVID-19 seroprevalence in Nigeria
Social vulnerability has been shown to be a strong predictor of disparities in health outcomes. A common approach to estimating social vulnerability is using a composite index, such as the social vulnerability index (SVI), which combines multiple factors corresponding to key social determinants of health. Lawal and Osayomi created an SVI to explore key social determinants of health-related COVID-19 infection among the Nigerian population. This study explored the association of COVID-19 SVI with COVID-19 seroprevalence using a large household survey in Nigeria. Weighted COVID-19 seroprevalence estimates at the Local Government Areas (LGA) were estimated and merged with the Lawal and Osayomi SVI, also at the LGA-level. Linear regression models were constructed to evaluate the relationship between the SVI and COVID-19 seroprevalence. The effect of SVI was evaluated both as a continuous variable and categorized into quintiles to evaluate dose-response effects. Our results confirmed a positive relationship between social vulnerability and COVID-19 infection in four states and the Federal Capital Territory in Nigeria. Compared to class 1 (the least vulnerable group), COVID-19 seroprevalence was, on average, 9.21% and 6.42% higher in classes 4 and 5 LGAs, respectively, after adjustment by phase of the survey. The effect was particularly strong farther into the pandemic (June 2021), when COVID-19 mitigation measures were relaxed. In conclusion, SVI can potentially be a useful tool to effectively prioritize communities for resource allocation as part of emergency response and preparedness in Africa.
- 21 December 2023
- Published by Springer Nature in AIDS and Behavior
- Vol. 28 (2) , 583-590
Effects of Multi-Month Dispensing on Clinical Outcomes: Retrospective Cohort Analysis Conducted in Kenya
Multi-month dispensing (MMD) has been widely adopted by national HIV programs as a key strategy for improving the quality of HIV care and treatment services while meeting the unique needs of diverse client populations. We assessed the clinical outcomes of clients receiving MMD in Kenya by conducting a retrospective cohort study using routine programmatic data in 32 government health facilities in Kenya. We included clients who were eligible for multi-month antiretroviral therapy (ART) dispensing for ≥ 3 months (≥ 3MMD) according to national guidelines. The primary exposure was enrollment into ≥ 3MMD. The outcomes were lost to follow-up (LTFU) and viral rebound. Multilevel modified-Poisson regression models with robust standard errors were used to compare clinical outcomes between clients enrolled in ≥ 3MMD and those receiving ART dispensing for less than 3 months (< 3MMD). A total of 3,501 clients eligible for ≥ 3MMD were included in the analysis, of whom 65% were enrolled in ≥ 3MMD at entry into the cohort. There was no difference in LTFU of ≥ 180 days between the two types of care (aRR 1.1, 95% CI 0.7–1.6), while ≥ 3MMD was protective for viral rebound (aRR 0.1 95% CI 0.0-0.2). As more diverse client-focused service delivery models are being implemented, robust evaluations are essential to guide the implementation, monitor progress, and assess acceptability and effectiveness to deliver optimal people-centered care.
- 21 December 2023
- Published by Springer Nature in AIDS and Behavior
- Vol. 28 (2) , 583-590
Effects of Multi-Month Dispensing on Clinical Outcomes: Retrospective Cohort Analysis Conducted in Kenya
Multi-month dispensing (MMD) has been widely adopted by national HIV programs as a key strategy for improving the quality of HIV care and treatment services while meeting the unique needs of diverse client populations. We assessed the clinical outcomes of clients receiving MMD in Kenya by conducting a retrospective cohort study using routine programmatic data in 32 government health facilities in Kenya. We included clients who were eligible for multi-month antiretroviral therapy (ART) dispensing for ≥ 3 months (≥ 3MMD) according to national guidelines. The primary exposure was enrollment into ≥ 3MMD. The outcomes were lost to follow-up (LTFU) and viral rebound. Multilevel modified-Poisson regression models with robust standard errors were used to compare clinical outcomes between clients enrolled in ≥ 3MMD and those receiving ART dispensing for less than 3 months (< 3MMD). A total of 3,501 clients eligible for ≥ 3MMD were included in the analysis, of whom 65% were enrolled in ≥ 3MMD at entry into the cohort. There was no difference in LTFU of ≥ 180 days between the two types of care (aRR 1.1, 95% CI 0.7–1.6), while ≥ 3MMD was protective for viral rebound (aRR 0.1 95% CI 0.0-0.2). As more diverse client-focused service delivery models are being implemented, robust evaluations are essential to guide the implementation, monitor progress, and assess acceptability and effectiveness to deliver optimal people-centered care.
- Open Access
- 18 July 2023
- Published by Taylor & Francis in Global Health Action
- Vol. 16 (1) , 2231256
Feasibility and acceptability of peer-delivered interventions using mHealth for PrEP services among adolescent girls and young women in DREAMS program in Botswana
Adolescent girls and young women accounted for 25% of all new HIV infections despite representing only 10% of the population in Sub Saharan Africa. PEPFAR has launched the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) initiative, a comprehensive HIV prevention program including PrEP services. Among adolescent girls and young women, PrEP adherence is currently sub-optimal. Tailored strategies for adolescent girls and young women to improve access and use of PrEP delivery are urgently needed to maximise its potential. Recommended interventions include peer-delivered interventions using mobile technology. However, data on the feasibility and acceptability of this approach is limited for SSA. We assessed the feasibility and perceived acceptability of providing mHealth peer-delivered interventions to support PrEP services among adolescent girls and young women in Botswana. This cross-sectional study included HIV-negative women aged 18–24 years old seeking health services at DREAMS-supported facilities. Participants completed a survey assessing the feasibility and perceived acceptability of the mHealth peer-delivered interventions, which included the Acceptability of Intervention Measure (AIM). Descriptive analyses were performed. A total of 131 participated in the study. Overall, 89% owned a mobile phone (feasibility). There was no difference in cell phone ownership between participants from rural and urban settings. Among participants, 85% reported interest in participating in a mHealth peer-delivered intervention if it was available to them. Regarding perceived acceptability for mHealthpeer support groups for PrEP, the average score on the AIM was 3.8 out of 5 (SD = 0.8). mHealthpeer-delivered interventions appear to be feasible and perceived acceptable among adolescent girls and young women in Botswana. This modality should be incorporated into PEPFAR’s programmatic toolkit of implementation strategies to improve PrEP services.
- 18 July 2023
- Published by Taylor & Francis in Global Health Action
- Vol. 16 (1) , 2231256
Open AccessFeasibility and acceptability of peer-delivered interventions using mHealth for PrEP services among adolescent girls and young women in DREAMS program in Botswana
Adolescent girls and young women accounted for 25% of all new HIV infections despite representing only 10% of the population in Sub Saharan Africa. PEPFAR has launched the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe (DREAMS) initiative, a comprehensive HIV prevention program including PrEP services. Among adolescent girls and young women, PrEP adherence is currently sub-optimal. Tailored strategies for adolescent girls and young women to improve access and use of PrEP delivery are urgently needed to maximise its potential. Recommended interventions include peer-delivered interventions using mobile technology. However, data on the feasibility and acceptability of this approach is limited for SSA. We assessed the feasibility and perceived acceptability of providing mHealth peer-delivered interventions to support PrEP services among adolescent girls and young women in Botswana. This cross-sectional study included HIV-negative women aged 18–24 years old seeking health services at DREAMS-supported facilities. Participants completed a survey assessing the feasibility and perceived acceptability of the mHealth peer-delivered interventions, which included the Acceptability of Intervention Measure (AIM). Descriptive analyses were performed. A total of 131 participated in the study. Overall, 89% owned a mobile phone (feasibility). There was no difference in cell phone ownership between participants from rural and urban settings. Among participants, 85% reported interest in participating in a mHealth peer-delivered intervention if it was available to them. Regarding perceived acceptability for mHealthpeer support groups for PrEP, the average score on the AIM was 3.8 out of 5 (SD = 0.8). mHealthpeer-delivered interventions appear to be feasible and perceived acceptable among adolescent girls and young women in Botswana. This modality should be incorporated into PEPFAR’s programmatic toolkit of implementation strategies to improve PrEP services.
- Open Access
- 30 May 2023
- Published by Academy of Science of South Africa in South African Journal of Science
- Vol. 119 (5/6)
Revealing human mobility trends during the SARS-CoV-2 pandemic in Nigeria via a data-driven approach
We employed emerging smartphone-based location data and produced daily human mobility measurements using Nigeria as an application site. A data-driven analytical framework was developed for rigorously producing such measures using proven location intelligence and data-mining algorithms. Our study demonstrates the framework at the beginning of the SARS-CoV-2 pandemic and successfully quantifies human mobility patterns and trends in response to the unprecedented public health event. Another highlight of the paper is the assessment of the effectiveness of mobility-restricting policies as key lessons learned from the pandemic. We found that travel bans and federal lockdown policies failed to restrict trip-making behaviour, but had a significant impact on distance travelled. This paper contributes a first attempt to quantify daily human travel behaviour, such as trip-making behaviour and travelling distances, and how mobility-restricting policies took effect in sub-Saharan Africa during the pandemic. This study has the potential to enable a wide spectrum of quantitative studies on human mobility and health in sub-Saharan Africa using well-controlled, publicly available large data sets. Significance: The mobility measurements in this study are new and have filled a major data gap in understanding the change in travel behaviour during the SARS-CoV-2 pandemic in Nigeria. These measurements are derived from high-quality data samples by state-of-the-art data-driven methodologies and could be further adopted by other quantitative research related to human mobility. Additionally, this study evaluates the impact of mobility-restricting policies and the heterogeneous effects of socio-economic and socio-demographic factors by a time-dependent random effect model on human mobility. The quantitative model provides a decision-making basis for the Nigerian government to provide travel-related guidance and make decisions in future public health events. Open data set: https://github.com/villanova-transportation/Nigeria-mobility-COVID19-SAJS
- 30 May 2023
- Published by Academy of Science of South Africa in South African Journal of Science
- Vol. 119 (5/6)
Open AccessRevealing human mobility trends during the SARS-CoV-2 pandemic in Nigeria via a data-driven approach
We employed emerging smartphone-based location data and produced daily human mobility measurements using Nigeria as an application site. A data-driven analytical framework was developed for rigorously producing such measures using proven location intelligence and data-mining algorithms. Our study demonstrates the framework at the beginning of the SARS-CoV-2 pandemic and successfully quantifies human mobility patterns and trends in response to the unprecedented public health event. Another highlight of the paper is the assessment of the effectiveness of mobility-restricting policies as key lessons learned from the pandemic. We found that travel bans and federal lockdown policies failed to restrict trip-making behaviour, but had a significant impact on distance travelled. This paper contributes a first attempt to quantify daily human travel behaviour, such as trip-making behaviour and travelling distances, and how mobility-restricting policies took effect in sub-Saharan Africa during the pandemic. This study has the potential to enable a wide spectrum of quantitative studies on human mobility and health in sub-Saharan Africa using well-controlled, publicly available large data sets. Significance: The mobility measurements in this study are new and have filled a major data gap in understanding the change in travel behaviour during the SARS-CoV-2 pandemic in Nigeria. These measurements are derived from high-quality data samples by state-of-the-art data-driven methodologies and could be further adopted by other quantitative research related to human mobility. Additionally, this study evaluates the impact of mobility-restricting policies and the heterogeneous effects of socio-economic and socio-demographic factors by a time-dependent random effect model on human mobility. The quantitative model provides a decision-making basis for the Nigerian government to provide travel-related guidance and make decisions in future public health events. Open data set: https://github.com/villanova-transportation/Nigeria-mobility-COVID19-SAJS
- Open Access
- 31 December 2022
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 13 (4) , 6
Development and implementation of clinical mentorship in Rwanda: successes and challenges
Rwanda has prioritized the decentralization and integration of HIV services over the past decade to ensure universal access to HIV services throughout the nation. Improving the capacity of healthcare providers to provide high-quality HIV prevention and treatment services was a crucial component of this process. In partnership with the authors, Rwanda’s national health implementation agency developed a national clinical mentorship program from 2011 to 2017 to facilitate this transition. The Rwanda Clinical Mentorship Model aims to effectively manage HIV-infected patients across all levels of healthcare delivery, implement task shifting, and adhere to national guidelines. The clinical care of HIV-positive individuals was transferred from HIV specialists to family physicians and nurses. The facility team was trained, supervised, and mentored by a multidisciplinary team. Mentorship consisted of routine site visits during which clinical case reviews, clinical supervision teaching, and data reviews were conducted to assess the facility’s performance and identify obstacles. Between 2012 and 2020, 5,774 healthcare professionals across the country received HIV testing and treatment training. This clinical mentoring has demonstrated a pragmatic, data-driven, and enduring strategy for enhancing clinical practice at all levels of care. A dedicated cadre of mentors is required to ensure the coordination and sustainability of this approach, according to one finding. The authors participated in accelerating the geographic and scope expansion of clinical mentoring in Rwanda. Developing a sustainable HIV clinical mentorship program in Rwanda requires longterm partnerships and evolving technical assistance.
- 31 December 2022
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 13 (4) , 6
Open AccessDevelopment and implementation of clinical mentorship in Rwanda: successes and challenges
Rwanda has prioritized the decentralization and integration of HIV services over the past decade to ensure universal access to HIV services throughout the nation. Improving the capacity of healthcare providers to provide high-quality HIV prevention and treatment services was a crucial component of this process. In partnership with the authors, Rwanda’s national health implementation agency developed a national clinical mentorship program from 2011 to 2017 to facilitate this transition. The Rwanda Clinical Mentorship Model aims to effectively manage HIV-infected patients across all levels of healthcare delivery, implement task shifting, and adhere to national guidelines. The clinical care of HIV-positive individuals was transferred from HIV specialists to family physicians and nurses. The facility team was trained, supervised, and mentored by a multidisciplinary team. Mentorship consisted of routine site visits during which clinical case reviews, clinical supervision teaching, and data reviews were conducted to assess the facility’s performance and identify obstacles. Between 2012 and 2020, 5,774 healthcare professionals across the country received HIV testing and treatment training. This clinical mentoring has demonstrated a pragmatic, data-driven, and enduring strategy for enhancing clinical practice at all levels of care. A dedicated cadre of mentors is required to ensure the coordination and sustainability of this approach, according to one finding. The authors participated in accelerating the geographic and scope expansion of clinical mentoring in Rwanda. Developing a sustainable HIV clinical mentorship program in Rwanda requires longterm partnerships and evolving technical assistance.